•  
  •  
  •  
  •  

2025-10-24 17:36:42

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Highway Infrastructure Ltd receives LOA worth ₹11.76 Crores for Toll Operations Contract by NHAI
  • BEML enters into MoU with Tesmec, S.p.A Italy
  • Stallion India Fluorochemicals Commences Groundwork for R-32 Manufacturing Facility in Bhilwara, Rajasthan
  • Crompton Greaves Consumer Electricals Ltd receives LOA from NREDCAP for EPC contracts
  • Kallam Textiles Ltd receives interest subsidy from Government of Andhra Pradesh

Keywords Selected:  Approval

IPO News

  • Rachit Prints Limited receives in-principle approval from BSE SME Exchange, Plans to Raise ₹19.50 Crore
  • Crizac Limited gets Sebi Nod for Rs 1,000 cr IPO
  • Jungle Camps India Limited plans to raise around Rs. 30 crores from IPO
  • Telangana-based Standard Glass Lining Technology Limited gets Sebi nod for IPO
  • IT Solutions provider Orient Technologies gets Sebi nod for IPO
  • Gala Precision Engineering gets Sebi nod for IPO
  • Noida-based Interarch Building Products Limited gets SEBI nod for IPO
  • Nephro Care India Limited plans to raise Rs. 35-40 crore from its upcoming IPO
  • Allied Blenders and Distillers Limited gets Sebi nod for Rs 1500 crore IPO
  • Sanstar Limited, gets SEBI nod to float IPO
  • Asirvad Micro Finance Limited gets Sebi nod for IPO
  • Kronox Lab Sciences gets SEBI nod to float IPO
  • Fairfax-backed Go Digit General Insurance gets Sebi nod for IPO
  • Gopal Snacks Limited gets Sebi nod for Rs 650 crore IPO
  • Juniper Hotels gets Sebi nod for its Rs 1,800 crore IPO
  • Stanley Lifestyles gets Sebi nod for IPO
  • Onest and Shiva Pharmachem gets Sebi nod for IPO
  • Mukka Proteins Limited gets Sebi Nod for IPO
  • Ludhiana-based Auto Component Maker Happy Forgings Limited receives Sebi nod to float its IPO
  • Cello World Limited gets Sebi nod for its Rs 1750 crore IPO
  • ESAF Small Finance Bank gets Sebi nod for IPO
  • MUFTI Owner Credo Brands Marketing gets Sebi nod for IPO
  • SAMHI Hotels and Motisons Jewellers gets Sebi nod for IPO
  • Jupiter Life Line Hospitals gets SEBI Nod for IPO

Stock Report

  • Biocon Biologics Receives Health Canada Approval for Yesintek™ and Yesintek™ I.V., a Biosimilar to Stelara®
  • MIC Electronics Limited receives approval of fresh registration from RDSO
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Triamcinolone Acetonide Injectable Suspension USP, 40 mg/mL
  • Relonchem Limited receives Marketing Authorization for two of its products
  • Standard Capital Markets Ltd commences Trading in Corporate Bonds after Obtaining CBRICS Registration from NSE
  • Biocon Pharma Ltd in partnership with Carnegie Pharmaceuticals LLC receives USFDA tentative approval for Rifaximin Tablets
  • Zydus receives approval from Health Canada for Liothyronine tablets 5 mcg and 25 mcg
  • Zydus receives final approval from USFDA for Deflazacort oral suspension, 22.75 mg/mL
  • FDC Ltd receives USFDA approval for ANDA Pilocarpine Hydrochloride Ophthalmic Solutions
  • Pune E Stock Broking Ltd receives SEBI nod to act as Merchant Banker
  • Lupin receives approval from U.S. FDA for Rivaroxaban for Oral Suspension
  • Ceigall India Subsidiary receives appointed date from NHAI for ₹981 Crore Ludhiana-Bathinda Greenfield Highway Project
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Paroxetine Extended Release Tablets USP, 25 mg and 37.5 mg.
  • UGRO Capital receives RBI approval for acquisition of Profectus Capital
  • Lupin receives approval from U.S. FDA for Lenalidomide Capsules
  • Kings Infra Welcomes EU's Approval of 102 Additional Indian Seafood Units
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Phytonadione Injectable Emulsion USP, 1 mg/0.5 mL Single-Dose Prefilled Syringe
  • Lupin receives U.S. FDA approval for Risperidone Long-Acting Injectable, with 180-Day CGT Exclusivity
  • Adani Power receives approval to commence Dhirauli Mine Operations
  • Eris Lifesciences receives ANVISA approval for Sterile Injectable Facility
  • Lehar Footwears Ltd receives BIS approval for PU Footwear products
  • Eris Lifesciences Receives ANVISA approval at its Ahmedabad campus
  • Madhvani Group Begins Formal Acquisition of HNGIL After NCLT Approval
  • CCS approves procurement of 97 LCA Mk-1A from HAL

Industry News

  • RBI grants NBFC license to Equirus Group
  • NCLT approves slice and North East Small Finance Bank's Merger
  • NSE launches WTI Crude Oil and Natural Gas futures contracts
  • Zero To One, an angel network, gets SEBI nod to launch INR 300cr Alternative Investment Fund
  • NTT DATA Payment Services accorded approval by RBI for payment aggregator license

Latest Post

  • Highway Infrastructure Ltd receives LOA worth ₹11.76 Crores for Toll Operations Contract by NHAI
  • BEML enters into MoU with Tesmec, S.p.A Italy
  • Stallion India Fluorochemicals Commences Groundwork for R-32 Manufacturing Facility in Bhilwara, Rajasthan
  • Crompton Greaves Consumer Electricals Ltd receives LOA from NREDCAP for EPC contracts
  • Kallam Textiles Ltd receives interest subsidy from Government of Andhra Pradesh


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024